Pragmabio
South San Francisco, United States · $10.0M raised
- Headquarters
- South San Francisco, California
- Website
- pragmabio.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series AMar 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biotechnology company that develops small-molecule therapeutics for immunological disorders, using real-world patient data and synthetic-biology-based drug discovery methods.
Summary
Pragmabio is a Biotech company based in South San Francisco, United States. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Mar 2023. Investors include The Venture Collective, Merck Global Health Innovation Fund and Viking Global.
Funding History
Mar 2023
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pragmabio"><img src="https://indexed.vc/api/badge/company/pragmabio" alt="Pragmabio on Indexed.vc" width="260" height="76" /></a>